TY - JOUR
T1 - Emerging importance of satellite glia in nervous system function and dysfunction
AU - Hanani, Menachem
AU - Spray, David C.
N1 - Funding Information:
The authors were supported by the Israel Science Foundation (ISF 508/13 and ISF 1297/18 to M.H.), US–Israel Binational Science Foundation (BSF-2011044 to M.H. and D.C.S.) and NIH (R01NS092786, R01NS092466 and R21NS116892 to D.C.S.).
Publisher Copyright:
© 2020, Springer Nature Limited.
PY - 2020/9/1
Y1 - 2020/9/1
N2 - Satellite glial cells (SGCs) closely envelop cell bodies of neurons in sensory, sympathetic and parasympathetic ganglia. This unique organization is not found elsewhere in the nervous system. SGCs in sensory ganglia are activated by numerous types of nerve injury and inflammation. The activation includes upregulation of glial fibrillary acidic protein, stronger gap junction-mediated SGC–SGC and neuron–SGC coupling, increased sensitivity to ATP, downregulation of Kir4.1 potassium channels and increased cytokine synthesis and release. There is evidence that these changes in SGCs contribute to chronic pain by augmenting neuronal activity and that these changes are consistent in various rodent pain models and likely also in human pain. Therefore, understanding these changes and the resulting abnormal interactions of SGCs with sensory neurons could provide a mechanistic approach that might be exploited therapeutically in alleviation and prevention of pain. We describe how SGCs are altered in rodent models of four common types of pain: systemic inflammation (sickness behaviour), post-surgical pain, diabetic neuropathic pain and post-herpetic pain.
AB - Satellite glial cells (SGCs) closely envelop cell bodies of neurons in sensory, sympathetic and parasympathetic ganglia. This unique organization is not found elsewhere in the nervous system. SGCs in sensory ganglia are activated by numerous types of nerve injury and inflammation. The activation includes upregulation of glial fibrillary acidic protein, stronger gap junction-mediated SGC–SGC and neuron–SGC coupling, increased sensitivity to ATP, downregulation of Kir4.1 potassium channels and increased cytokine synthesis and release. There is evidence that these changes in SGCs contribute to chronic pain by augmenting neuronal activity and that these changes are consistent in various rodent pain models and likely also in human pain. Therefore, understanding these changes and the resulting abnormal interactions of SGCs with sensory neurons could provide a mechanistic approach that might be exploited therapeutically in alleviation and prevention of pain. We describe how SGCs are altered in rodent models of four common types of pain: systemic inflammation (sickness behaviour), post-surgical pain, diabetic neuropathic pain and post-herpetic pain.
UR - http://www.scopus.com/inward/record.url?scp=85088382141&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088382141&partnerID=8YFLogxK
U2 - 10.1038/s41583-020-0333-z
DO - 10.1038/s41583-020-0333-z
M3 - Review article
C2 - 32699292
AN - SCOPUS:85088382141
SN - 1471-003X
VL - 21
SP - 485
EP - 498
JO - Nature Reviews Neuroscience
JF - Nature Reviews Neuroscience
IS - 9
ER -